1152311-62-0
- Product Name:Tezacaftor
- Molecular Formula:C26H27F3N2O6
- Purity:99%
- Molecular Weight:520.5
Product Details:
CasNo: 1152311-62-0
Molecular Formula: C26H27F3N2O6
Appearance: Off‑white to pale yellow
Packing: Aluminium bag
Throughput: 100KG/Month
Purity: 99%
Physical‑Chemical Properties
Appearance: White to off‑white powderDailyMed Practically insoluble in water, soluble in selected organic solventsDailyMed.
Mechanism of Action
Tezacaftor is a CFTR corrector. It improves protein folding, cellular processing and intracellular trafficking of mutant CFTR protein (including F508del mutation), increasing the quantity of mature CFTR protein transported to epithelial cell surfaceDailyMed. It is generally used in combination with ivacaftor (CFTR potentiator) or elexacaftor+ivacaftor triple‑combination regimen to restore chloride‑channel function, reduce thick mucus accumulation in lungs and improve cystic‑fibrosis clinical symptomsPMC. Compared with lumacaftor, tezacaftor shows less CYP‑mediated drug‑drug interaction and better safety profilePMC.
Indications
Tezacaftor is used in combination therapy for the treatment of cystic fibrosis (CF)DailyMed:
- In combination with ivacaftor (Symdeko / Symkevi): for cystic‑fibrosis patients aged 6 years and older, who are homozygous for the F508del mutation or carry responsive CFTR gene mutationsDailyMed.
- In triple‑combination with elexacaftor and ivacaftor (Trikafta): for cystic‑fibrosis patients aged 2 years and older with at least one F508del CFTR gene mutation or other responsive CFTR mutationsFDA Access....
Note: Tezacaftor has no approved therapeutic effect when used as monotherapy; clinical efficacy relies on combination with CFTR potentiator(s)DailyMed.
API Quality Profile
- HPLC Purity: NLT 98.0%
- Total impurities: ≤1.0%, single unknown impurity ≤0.15%
- Loss on drying: ≤0.5%
- COA, HPLC, NMR, MS documents available for R&D and formulation development. No official EP/USP pharmacopoeia monograph published yet.
Storage & Packing
Store sealed, protected from moisture and light, under cool‑dry conditions. Available packing: 1g, 5g, 10g, 100g, 1kg aluminium foil bag / drum for lab‑scale and pilot production.
Disclaimer
This product description serves for pharmaceutical raw‑material reference only, not for clinical medication guidance.
Relevant Products
-
Pralsetinib
CAS:2097132-94-8
-
Zoliflodacin
CAS:1245732-48-2
-
Elexacaftor
CAS:2216712-66-0





